Product Candidate Target Indication Global Rights Pre-clinical Phase I Phase II/III
Cell Therapies Conventional
CT053
BCMA Multiple myeloma
CT041
CLDN18.2 Gastric cancer / pancreatic cancer
CT011
GPC3 Hepatocellular carcinoma
CT032
CD19 B-cell non-Hodgkin lymphoma
Next-Gen
CT017
GPC3 Hepatocellular carcinoma
KJ-C1807
CLDN18.2 Gastric cancer / pancreatic cancer
KJ-C2112
EGFR/EGFRvIII Glioblastoma
KJ-C2113
Mesothelin Solid tumor
Allogeneic
KJ-C2114
Undisclosed Solid tumor
KJ-C2111
BCMA Multiple myeloma
mAb
AB011
CLDN18.2 Gastric cancer / pancreatic cancer
China IND trial
China Investigator-initiated trial
Row rest of world